Document Detail


Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth.
MedLine Citation:
PMID:  1391266     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This prospective study was designed to assess pulmonary function (functional residual capacity, FRC; dynamic lung compliance, CLdyn; and total pulmonary resistance, RL) at 1 year of corrected age in infants with neonatal respiratory distress syndrome treated with natural porcine surfactant (Curosurf) (n = 13), as compared to nontreated control infants (n = 9). Values from 21 healthy infants of similar age served as reference. We found similar pulmonary dysfunction (decreased CLdyn, elevated RL) in both patient groups. These results suggest that surfactant replacement therapy does not affect pulmonary function at 1 year of age in infants who survive respiratory distress syndrome.
Authors:
H Walti; M Boulé; G Moriette; J P Relier
Related Documents :
19587566 - Hypoxia in the term newborn: part three--sepsis and hypotension, neurologic, metabolic ...
10535826 - Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving aspirin.
10802846 - Congenital misalignment of pulmonary vessels and alveolar capillary dysplasia: how to m...
12605006 - The use of pulmonary interstitial emphysema as an indicator of live birth.
3559456 - Adrenal status during the first month of life in mature and premature human infants.
12083296 - Facilitation of parenting the premature infant within the newborn intensive care unit.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Biology of the neonate     Volume:  61 Suppl 1     ISSN:  0006-3126     ISO Abbreviation:  Biol. Neonate     Publication Date:  1992  
Date Detail:
Created Date:  1992-11-18     Completed Date:  1992-11-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0247551     Medline TA:  Biol Neonate     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  48-53     Citation Subset:  IM    
Affiliation:
Service de Médecine Néonatale, Hôpital Port-Royal, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Airway Resistance / drug effects
Biological Products*
Follow-Up Studies
Functional Residual Capacity / drug effects
Humans
Infant
Infant, Low Birth Weight
Infant, Newborn
Lung / drug effects
Lung Compliance / drug effects
Phospholipids*
Prospective Studies
Pulmonary Surfactants / pharmacology*
Respiratory Distress Syndrome, Newborn / drug therapy,  mortality
Respiratory Mechanics / drug effects*
Chemical
Reg. No./Substance:
0/Biological Products; 0/Phospholipids; 0/Pulmonary Surfactants; 129069-19-8/poractant alfa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lung mechanics (FRC and static pressure-volume diagram) after endotracheal surfactant instillation: ...
Next Document:  Surfactant replacement therapy and the prevalence of acute retinopathy of prematurity.